ASCAT Remains a Platform for Knowledge Exchange, Collaboration and Progress Beyond the Room
Academy For Sickle Cell & Thalassaemia shared a post on LinkedIn:
“Saturday may have been smaller in numbers, but the energy never dropped. Conversations in the closing sessions, panels and side meetings carried the same commitment we’ve seen all week.
The community showed up with purpose — sharing learning, asking questions and creating space for what comes next. There was a strong sense of reflection and responsibility as people prepared to take insights back into practice, research, policy and service delivery.
The conference may be over, but this is the time to stay engaged and connected. ASCAT remains a platform for knowledge exchange, collaboration and progress beyond the room.
Thank you to everyone who travelled, contributed and stayed with us to the end.”
Stay informed with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator